1.
Holbro A, Jotterand M, Passweg JR, Buser A, Tichelli A, Rovó A. Comment to “Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation” Haematologica. 2012;97(12):1845-9. Haematologica 2013; 98(4):e46-e47; https://doi.org/10.3324/haematol.2012.082875.